Publicatie

Publicatie datum

Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.

Reedijk, M., Huss, A., Verheij, R.A., Peeters, P.H., Vermeulen, R.C.H. Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources. PLoS One: 2020, 15(7), p. Art. nr. e0234845.
Lees online
Background
Epidemiological evidence from prospective cohort studies on risk factors of Parkinson's disease (PD) is limited as case ascertainment is challenging due to a lack of registries and the disease course of PD.

Objective
The objective of this study was to create a case ascertainment method for PD within two prospective Dutch cohorts based on multiple sources of PD information.

Methode
This method was validated using clinical records from the general practitioners (GPs). Face validity of the case ascertainment was tested for three etiological factors (smoking, sex and family history of PD). In total 54825 participants were included from the cohorts AMIGO and EPIC-NL. Sources of PD information included self-reported PD, self-reported PD medication, a 9 item screening questionnaire (Tanner), electronical medical records, hospital discharge data and mortality records. Based on these sources we developed a likelihood score with 4 categories (no PD, unlikely PD, possible PD, likely PD). For the different sources of PD information and for the likelihood score we present the agreement with GP-validated cases. Risk of PD for established factors was studied by logistic regression as exact diagnose dates were not always available.

Findings
Based on the algorithm, we assigned 346 participants to the likely PD category. GP validation confirmed 67% of these participants in EPIC-NL, but only 12% in AMIGO. PD was confirmed in only 3% of the participants with a possible PD classification. PD case ascertainment by mortality records (91%), EMR ICPC (82%) and self-reported information (62-69%) had the highest confirmation rates. The Tanner PD screening questionnaire had a lower agreement (18%). Risk estimates for smoking, family history and sex using all likely PD cases were comparable to the literature for EPIC-NL, but not for smoking in AMIGO.

Conclusion
Using multiple sources of PD evidence in cohorts remains important but challenging as performance of sources varied in validity.